The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study
Ana Vagos Mata(Hospital de Santa Maria), Élie Azoulay(Hôpital Saint-Louis), Darmon Mm(Assistance Publique – Hôpitaux de Paris), Muriel Picard(Institut universitaire du cancer de Toulouse Oncopole), Roberta Di Blasi(Assistance Publique – Hôpitaux de Paris), Adel Maamar(Centre Hospitalier Universitaire de Rennes), Nahéma Issa(Bordeaux Population Health), Lara Zafrani(Inserm), Sandrine Valade(Inserm), Victoria Metaxa(Apple (Israel)), Philippe R. Bauer(Mayo Clinic in Florida), Alice Gallo de Moraes(Mayo Clinic), Boris Böll(University Hospital Cologne), Andry Van de Louw(Penn State Milton S. Hershey Medical Center), Sanjay Chawla(Memorial Sloan Kettering Cancer Center), Kada Klouche(Centre National de la Recherche Scientifique), Laveena Munshi(University of Toronto), Nicolas Boissel(Inserm), Gabriel Moreno‐González(Bellvitge University Hospital), Pedro Castro(Hospital Clínic de Barcelona), C Thieblemont(Université Paris Cité), Antoine F. Carpentier(Université Paris Cité), Florent Wallet(Hôpital Lyon Sud), Sara Fernández(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Joannidis M(Innsbruck Medical University), A Moreau(Centre Hospitalier Universitaire de Lille), Djamel Mokart(Institut Paoli-Calmettes), Amélie Seguin
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777